Why the study?
Does losartan alter angiotensin II receptor gene expression in rats with left ventricular hypertrophy induced by aortic banding?
Does losartan alter angiotensin II receptor gene expression in rats with left ventricular hypertrophy induced by aortic banding?
In a rat model of pressure overload-induced left ventricular hypertrophy, losartan ameliorated hypertrophy without altering the expression levels of angiotensin II AT1a, AT1b, and AT2 receptor genes.
Answers are grounded in this paper and cite their sources.
Losartan attenuates LVH without altering AT receptor mRNA in this rat model; leaves open receptor-independent mechanisms and human relevance.
OBJECTIVE: To examine the expression of angiotensin II AT1a, AT1b and AT2 receptor genes in the left ventricles of rats subjected to ventricular pressure overloading induced by aortic banding for 6 weeks and then 6 weeks medical treatment. RESULTS: Aortic banding was related to an increase in relative weight of the left ventricle from 1.73 +/- 0.06 (sham-operated) to 2.81 +/- 0.25 g/kg, an increase in beta-myosin: alpha-myosin messenger RNA (mRNA) ratio from 0.30 +/- 0.02 to 1.94 +/- 0.55 and an 18-fold increase in left ventricular atrial natriuretic peptide mRNA levels. In contrast, left ventricular pressure overload hypertrophy was not related to a significant change in the abundance of AT1a and AT1b mRNA, which were expressed in a relative ratio of 5:1. Similarly, the abundance of AT2 mRNA was not significantly changed in hypertrophied ventricles. In rats receiving the angiotensin II AT, receptor antagonist losartan (40 mg/kg) for 6 weeks after banding, relative heart weights were 2.39 +/- 0.14 g/kg, the beta-myosin: alpha-myosin ratio was 1.04 +/- 0.20 and atrial natriuretic peptide mRNA levels displayed a blunted increase (11-fold over sham-treated controls), documenting a significant amelioration of left ventricular hypertrophy by blockade of the AT1 receptor. CONCLUSION: Losartan treatment in parallel did not affect AT1a, AT1b and AT2 receptor mRNA levels, which were not different from those in vehicle-treated or sham-treated controls. These findings confirm that left ventricular hypertrophy in the rat is associated with increased ventricular expression of beta-myosin and of atrial natriuretic peptide and with reduced expression of alpha-myosin. Despite these significant changes in cardiac gene expression no alteration was observed in AT1a, AT1b and AT2 receptor mRNA levels.
No takes yet. Share an insight, caveat, or question.
Wolf et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: